EGF and non-small cell lung carcinoma: CIMAvax-EGF is a therapeutic cancer vaccine of human recombinant epidermal growth factor (EGF) conjugated to a carrier protein from Neisseria meningitides. The vaccine induces antibodies against EGF and confers a survival advantage in patients with non-small-cell lung cancer [80].